Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Multiple sclerosis, interferon beta and clinical thyroid dysfunction.

A Kreisler¹, J de Seze, T Stojkovic

¹Department of Neurology, Lille University Hospital, France.

Acta Neurologica Scandinavica

|February 13, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Same author

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Revue neurologique·2025

Same author

Teriflunomide, cognition and MRI: A longitudinal study.

Multiple sclerosis and related disorders·2024

Same author

Clinical applications of deep learning in neuroinflammatory diseases: A scoping review.

Revue neurologique·2024

Same author

Does the guidance method affect the doses of botulinum toxin in writer's cramp?

Revue neurologique·2024

Same author

What you feel is not always what you've got. Jean Lhermitte (1877-1959) and the phantom limb phenomenon.

Revue neurologique·2023

Same journal

Editorial.

Acta neurologica Scandinavica·2022

Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022

Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022

Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022

Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022

Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022

See all related articles

Interferon beta (IFN-beta) treatment for multiple sclerosis can cause clinical thyroid dysfunction, though it is rare. This side effect, including hyperthyroidism and hypothyroidism, can be severe and requires monitoring.

Area of Science:

Neurology
Endocrinology
Immunology

Background:

Interferon beta (IFN-beta) is a common treatment for multiple sclerosis (MS).
Thyroid dysfunction is a potential adverse effect of various medications.

Observation:

This study analyzed 700 patients with MS treated with IFN-beta.
Clinical thyroid dysfunction was observed in a small subset of patients.

Findings:

Five patients on IFN-beta1b developed hyperthyroidism; three required treatment cessation.
Two patients on IFN-beta1a developed hypothyroidism, one requiring thyroid hormone replacement.
One patient on IFN-beta1a showed increased thyroid volume without hormonal changes.

Implications:

Related Experiment Videos

Clinical thyroid dysfunction is a rare but significant side effect of IFN-beta therapy in MS patients.
Monitoring thyroid function is crucial for patients undergoing IFN-beta treatment.
The severity of thyroid dysfunction necessitates careful patient management and potential treatment adjustments.